244 related articles for article (PubMed ID: 10742150)
1. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
[TBL] [Abstract][Full Text] [Related]
2. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
4. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
6. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
8. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains.
Klingel K; Kandolf R
Scand J Infect Dis Suppl; 1993; 88():79-85. PubMed ID: 8390720
[TBL] [Abstract][Full Text] [Related]
9. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
[TBL] [Abstract][Full Text] [Related]
11. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
12. TRIF is a critical survival factor in viral cardiomyopathy.
Riad A; Westermann D; Zietsch C; Savvatis K; Becher PM; Bereswill S; Heimesaat MM; Lettau O; Lassner D; Dörner A; Poller W; Busch M; Felix SB; Schultheiss HP; Tschöpe C
J Immunol; 2011 Feb; 186(4):2561-70. PubMed ID: 21239721
[TBL] [Abstract][Full Text] [Related]
13. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
14. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
15. Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.
Nishtala K; Phong TQ; Steil L; Sauter M; Salazar MG; Kandolf R; Kroemer HK; Felix SB; Völker U; Klingel K; Hammer E
Proteomics; 2011 Nov; 11(22):4310-20. PubMed ID: 21954127
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of PDGF-C in coxsackievirus B3-induced chronic myocarditis.
Grün K; Markova B; Böhmer FD; Berndt A; Kosmehl H; Leipner C
Eur Heart J; 2005 Apr; 26(7):728-39. PubMed ID: 15757958
[TBL] [Abstract][Full Text] [Related]
18. [The molecular pathogenesis of enterovirus myocarditis. Virus persistence and chronic inflammation].
Kandolf R
Internist (Berl); 1995 May; 36(5):430-8. PubMed ID: 7601616
[No Abstract] [Full Text] [Related]
19. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
20. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
Qian Q; Xiong S; Xu W
Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]